RBC Capital Keeps Their Hold Rating on Pacira Pharmaceuticals (PCRX) | Markets Insider

Retrieved on: 2025-04-05 08:36:22

Tags for this article:

Click the tags to see associated articles and topics

RBC Capital Keeps Their Hold Rating on Pacira Pharmaceuticals (PCRX) | Markets Insider. View article details on hiswai:

Excerpt

Don't Miss Our End of Quarter Offers: · Pacira announces first patient dosed in Phase 2 ASCEND study of PCRX-201 · Biotech stocks slide as Marks ...

Article found on: markets.businessinsider.com